World allergy organization anaphylaxis guidelines: 2013 update of the evidence base

International Archives of Allergy and Immunology

Volumn 162, Issue 3, 2013, Pages 193-204

  Simons, F Estelle R ^a   Ardusso, Ledit R F ^b   Dimov, Vesselin ^c   Ebisawa, Motohiro ^e   El Gamal, Yehia M ^f   Lockey, Richard F ^d   Sanchez Borges, Mario ^g   Senna, Gian Enrico ^h   Sheikh, Aziz ⁱ   Thong, Bernard Y ^j   Worm, Margitta ^k  

^a UNIVERSITY OF MANITOBA   (Canada)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^f AIN SHAMS UNIVERSITY   (Egypt)

^g Centro Medico Docente La Trinidad   (Venezuela)

^h Verona General Hospital   (Italy)

ⁱ UNIVERSITY OF EDINBURGH   (United Kingdom)

^j TAN TOCK SENG HOSPITAL   (Singapore)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

Adrenaline; Anaphylaxis; Auto injector; Drug allergy; Epinephrine; Exercise induced anaphylaxis; Food allergy; Insect venom allergy; Latex allergy; Systemic allergic reaction

Indexed keywords

ADRENALIN; ALCOHOL; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; FOOD ALLERGEN; GLUCOCORTICOID; HYMENOPTERA VENOM; IMMUNOMODULATING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PROTON PUMP INHIBITOR; RECOMBINANT ALLERGEN; RITUXIMAB; VENOM;

ANAPHYLAXIS; ASTHMA; CARDIOVASCULAR DISEASE; DRUG HYPERSENSITIVITY; EXERCISE; FOOD ALLERGY; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LABORATORY TEST; MASTOCYTOSIS; POLLEN ALLERGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RESUSCITATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SELF CARE; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW (TOPIC); SYSTEMIC MASTOCYTOSIS;

EID: 84887095867     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000354543     Document Type: Review

References (88)

1. Simons FER, Ardusso LRF, Bilo MB, El-Gamal YM, Ledford DK, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY, for the World Allergy Organization: World Allergy Organization guidelines for the assessment and management of anaphylaxis. J Allergy Clin Immunol 2011; 127: 593.e1-e22.
2. Simons FER, Ardusso LRF, Bilo MB, Dimov V, Ebisawa M, El-Gamal YM, Ledford DK, Lockey RF, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY, Worm M, for the World Allergy Organization: 2012 Update: World Allergy Organization (WAO) guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012; 12: 389-399.
3. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SGA, Camargo CA Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FER, Thomas S, Wood JP, Decker WW: Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol 2006; 117: 391-397.
4. Worm M, Edenharter G, Rueff F, Scherer K, Pfohler C, Mahler V, Treudler R, Lang R, Nemat K, Koehli A, Niggemann B, Hompes S: Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012; 67: 691-698.
5. Tejedor Alonso MA, Moro Moro M, Mugica Garcia MV, Esteban Hernandez J, Rosado Ingelmo A, Vila Albelda C, Gomez Traseira C, Cardenas Contreras R, Sanz Sacristan J, Hernandez Merino A: Incidence of anaphylaxis in the city of Alcorcon (Spain): a populationbased study. Clin Exp Allergy 2012; 42: 578-589.
6. Cetinkaya F, Incioglu A, Birinci S, Karaman BE, Dokucu AI, Sheikh A: Hospital admissions for anaphylaxis in Istanbul, Turkey. Allergy 2013; 68: 128-130.
7. Steele R, Camacho-Halili M, Rosenthal B, Davis-Lorton M, Aquino M, Fonacier L: Anaphylaxis in the community setting: determining risk factors for admission. Ann Allergy Asthma Immunol 2012; 109: 133-136.
8. Gibbison B, Sheikh A, McShane P, Haddow C, Soar J: Anaphylaxis admissions to UK critical care units between 2005 and 2009. Anaesthesia 2012; 67: 833-839.
9. Tanno LK, Ganem F, Demoly P, Toscano CM, Bierrenbach AL: Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy 2012; 67: 783-789.
10. Gelincik A, Demirturk M, Yilmaz E, Ertek B, Erdogdu D, Colakoglu B, Buyukozturk S: Anaphylaxis in a tertiary adult allergy clinic: a retrospective review of 516 patients. Ann Allergy Asthma Immunol 2013; 110: 96-100.
11. Beyer K, Eckermann O, Hompes S, Grabenhenrich L, Worm M: Anaphylaxis in an emergency setting - elicitors, therapy and incidence of severe allergic reactions. Allergy 2012; 67: 1451-1456.
12. Lee S, Hess EP, Nestler DM, Bellamkonda Athmaram VR, Bellolio MF, Decker WW, Li JTC, Hagan JB, Manivannan V, Vukov SC, Campbell RL: Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis. J Allergy Clin Immunol 2013; 131: 1103-1108.
13. Vetander M, Helander D, Flodstrom C, Ostblom E, Alfven T, Ly DH, Hedlin G, Lilja G, Nilsson C, Wickman M: Anaphylaxis and reactions to foods in children - a populationbased case study of emergency department visits. Clin Exp Allergy 2012; 42: 568-577.
14. Levy MB, Goldberg MR, Nachshon L, Tabachnik E, Katz Y: Lessons from cases of mortality due to food allergy in Israel: cow's milk protein should be considered a potentially fatal allergen. Isr Med Assoc J 2012; 14: 29-33.
15. Valent P: Mast cell activation syndromes: definition and classification. Allergy 2013; 68: 417-424.
16. Alvarez-Twose I, Vano-Galvan S, Sanchez-Munoz L, Morgado JM, Matito A, Torrelo A, Jaen P, Schwartz LB, Orfao A, Escribano L: Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy 2012; 67: 813-821.
17. Alvarez-Twose I, Bonadonna P, Matito A, Zanotti R, Gonzalez-de-Olano D, Sanchez-Munoz L, Morgado JM, Orfao A, Escribano L: Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis. J Allergy Clin Immunol 2013; 131: 614-615.
18. Stoevesandt J, Hain J, Kerstan A, Trautmann A: Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema. J Allergy Clin Immunol 2012; 130: 698-704.
19. Brockow K, Bonadonna P: Drug allergy in mast cell disease. Curr Opin Allergy Clin Immunol 2012; 12: 354-360.
20. Asero R, Farioli L, Pastorello EA: Baseline serum tryptase levels and adverse reactions to injection specific immunotherapy with airborne allergens: is there a relationship? Int Arch Allergy Immunol 2012; 158: 276-280.
21. Cardona V, Luengo O, Garriga T, Labrador-Horrillo M, Sala-Cunill A, Izquierdo A, Soto L, Guilarte M: Co-factor-enhanced food allergy. Allergy 2012; 67: 1316-1318.
22. Hong X, Caruso D, Kumar R, Liu R, Liu X, Wang G, Pongracic JA, Wang X: IgE, but not IgG4, antibodies to Ara h 2 distinguish peanut allergy from asymptomatic peanut sensitization. Allergy 2012; 67: 1538-1546.
23. Chiang WC, Huang Chiung-H, Llanora GV, Gerez I, Goh SH, Shek LPC, Nauta AJ, Van Doorn WA, Bindels J, Ulfman LH, Knipping K, Delsing DJ, Knol EF, Lee BW: Anaphylaxis to cow's milk formula containing shortchain galacto-oligosaccharide. J Allergy Clin Immunol 2012; 130: 1361-1367.
24. Sanchez-Borges M, Suarez Chacon R, Capriles-Hulett A, Caballero-Fonseca F, Fernandez-Caldas E: Anaphylaxis from ingestion of mites: pancake anaphylaxis. J Allergy Clin Immunol 2013; 131: 31-35.
25. Mullins RJ, James H, Platts-Mills TAE, Commins S: Relationship between red meat allergy and sensitization to gelatin and galactose-alpha- 1, 3-galactose. J Allergy Clin Immunol 2012; 129: 1334-1342.e1.
26. Caballero ML, Umpierrez A, Perez-Pinar T, Moneo I, de Burgos C, Asturias JA, Rodriguez-Perez R: Anisakis simplex recombinant allergens increase diagnosis specificity preserving high sensitivity. Int Arch Allergy Immunol 2012; 158: 232-240.
27. Chernin LR, Swender DA, Hostoffer RW, Tcheurekdjian H: Anaphylaxis secondary to contact with a vomited food allergen. Ann Allergy Asthma Immunol 2012; 109: 279.
28. Armentia A, Pineda F, Martin B, San Miguel A, Gil FJM, Puente Y, de Lecea C, Palacios R: Anaphylaxis caused by hidden soybean allergens in pillows. J Allergy Clin Immunol 2013; 131: 228-230.
29. Hofmann SC, Fischer J, Eriksson C, Bengtsson Gref O, Biedermann T, Jakob T: IgE detection to alpha/beta/gamma-gliadin and its clinical relevance in wheat-dependent exercise- induced anaphylaxis. Allergy 2012; 67: 1457-1460.
30. Takahashi H, Matsuo H, Chinuki Y, Kohno K, Tanaka A, Maruyama N, Morita E: Recombinant high molecular weight-glutenin subunit- specific IgE detection is useful in identifying wheat-dependent exercise-induced anaphylaxis complementary to recombinant omega-5 gliadin-specific IgE test. Clin Exp Allergy 2012; 42: 1293-1298.
31. Muller U, Schmid-Grendelmeier P, Hausmann O, Helbling A: IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy. Allergy 2012; 67: 1069-1073.
32. Ebo DG, Faber M, Sabato V, Leysen J, Bridts CH, De Clerck LS: Component-resolved diagnosis of wasp (yellow jacket) venom allergy. Clin Exp Allergy 2013; 43: 255-261.
33. Ribeiro-Vaz I, Marques J, Demoly P, Polonia J, Gomes ER: Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority. Eur J Clin Pharmacol 2013; 69: 673-681.
34. Ramirez E, Cabanas R, Laserna LS, Fiandor A, Tong H, Prior N, Calderon O, Medrano N, Bobolea I, Frias J, Quirce S: Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case-control in a retrospective cohort study. Clin Exp Allergy 2013; 43: 344-352.
35. Rutkowski K, Nasser SM, Ewan PW: Paracetamol hypersensitivity: clinical features, mechanism and role of specific IgE. Int Arch Allergy Immunol 2012; 159: 60-64.
36. Brereton A, Russell WJ: Anaphylaxis to muscle relaxants: an audit of ten years of allergy testing at the Royal Adelaide Hospital. Anaesth Intensive Care 2012; 40: 861-866.
37. Vultaggio A, Matucci A, Nencini F, Pratesi S, Petroni G, Cammelli D, Alterini R, Rigacci L, Romagnani S, Maggi E: Drug-specific Th2 cells and IgE antibodies in a patient with anaphylaxis to rituximab. Int Arch Allergy Immunol 2012; 159: 321-326.
38. Accetta Pedersen DJ, Klancnik M, Elms N, Wang ML, Hoffmann RG, Kurup VP, Kelly KJ: Analysis of available diagnostic tests for latex sensitization in an at-risk population. Ann Allergy Asthma Immunol 2012; 108: 94-97.
39. Unsel M, Mete N, Ardeniz O, Sin A, Gulbahar O, Kokuludag A: Diagnostic value of specific IgE analysis in latex allergy. Int Arch Allergy Immunol 2012; 158: 281-287.
40. Romano A, Scala E, Rumi G, Gaeta F, Caruso C, Alonzi C, Maggioletti M, Ferrara R, Palazzo P, Palmieri V, Zeppilli P, Mari A: Lipid transfer proteins: the most frequent sensitizer in Italian subjects with food-dependent exercise- induced anaphylaxis. Clin Exp Allergy 2012; 42: 1643-1653.
41. Basagana M, Bartolome B, Pastor-Vargas C, Mattsson L, Lidholm J, Labrador-Horrillo M: Involvement of Can f 5 in a case of human seminal plasma allergy. Int Arch Allergy Immunol 2012; 159: 143-146.
42. Minciullo PL, Cascio A, David A, Pernice LM, Calapai G, Gangemi S: Anaphylaxis caused by helminths: review of the literature. Eur Rev Med Pharmacol Sci 2012; 16: 1513-1518.
43. Hoekstra M, van der Heide S, Coenraads PJ, Schuttelaar MLA: Anaphylaxis and severe systemic reactions caused by skin contact with persulfates in hair-bleaching products. Contact Dermatitis 2012; 66: 317-322.
44. Park HJ, Kim SH: Factors associated with shock in anaphylaxis. Am J Emerg Med 2012; 30: 1674-1678.
45. Caffarelli C, Rico S, Rinaldi L, Povesi Dascola C, Terzi C, Bernasconi S: Blood pressure monitoring in children undergoing food challenge: association with anaphylaxis. Ann Allergy Asthma Immunol 2012; 108: 285-286.
46. Mingomataj EC, Bakiri AH: Episodic hemorrhage during honeybee venom anaphylaxis: potential mechanisms. J Investig Allergol Clin Immunol 2012; 22: 237-244.
47. Bork K, Hardt J, Witzke G: Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol 2012; 130: 692-697.
48. Sala-Cunill A, Cardona V, Labrador-Horrillo M, Luengo O, Esteso O, Garriga T, Vicario M, Guilarte M: Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol 2013; 160: 192-199.
49. Belhocine W, Ibrahim Z, Grandne V, Buffat C, Robert P, Gras D, Cleach I, Bongrand P, Carayon P, Vitte J: Total serum tryptase levels are higher in young infants. Pediatr Allergy Immunol 2011; 22: 600-607.
50. Vadas P, Perelman B, Liss G: Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. J Allergy Clin Immunol 2013; 131: 144-149.
51. Vadas P, Perelman B: Effect of epinephrine on platelet-activating factor-stimulated human vascular smooth muscle cells. J Allergy Clin Immunol 2012; 129: 1329-1333.
52. Rudders SA, Geyer BC, Banerji A, Phipatanakul W, Clark S, Camargo CA Jr: Obesity is not a risk factor for repeat epinephrine use in the treatment of anaphylaxis. J Allergy Clin Immunol 2012; 130: 1216-1218.
53. Ellis BC, Brown SGA: Parenteral antihistamines cause hypotension in anaphylaxis. Emerg Med Australas 2013; 25: 92-93.
54. Choo KJL, Simons FER, Sheikh A: Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev 2012; 4:CD007596.
55. Grabenhenrich L, Hompes S, Gough H, Rueff F, Scherer K, Pfohler C, Treudler R, Mahler V, Hawranek T, Nemat K, Koehli A, Keil T, Worm M: Implementation of anaphylaxis management guidelines: a register-based study. PLoS One 2012; 7:e35778.
56. Perel P, Roberts I, Ker K: Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; 2:CD000567.
57. Bauer CS, Vadas P, Kelly KJ: Methylene blue for the treatment of refractory anaphylaxis without hypotension. Am J Emerg Med 2013; 31: 264.e3-e5.
58. Jang DH, Nelson LS, Hoffman RS: Methylene blue for distributive shock: a potential new use of an old antidote. J Med Toxicol 2013; DOI: 10.1007/s13181.
59. Simons FER, Schatz M: Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012; 130: 597-606.
60. Fleischer DM, Perry TT, Atkins D, Wood RA, Burks AW, Jones SM, Henning AK, Stablein D, Sampson HA, Sicherer SH: Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics 2012; 130:e25-e32.
61. Nguyen-Luu NU, Ben-Shoshan M, Alizadehfar R, Joseph L, Harada L, Allen M, St-Pierre Y, Clarke A: Inadvertent exposures in children with peanut allergy. Pediatr Allergy Immunol 2012; 23: 133-139.
62. Sheikh A, Simons FER, Barbour V, Worth A: Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community. Cochrane Database Syst Rev 2012; 8:CD008935.
63. Gupta P, Gerrish PK, Silverman B, Schneider A: Current practices among allergists on writing self-injectable epinephrine prescriptions for immunotherapy patients. J Allergy Clin Immunol 2012; 129: 571-572.e1-e2.
64. Topal E, Bakirtas A, Yilmaz O, Ertoy IH, Arga M, Demirsoy MS, Turktas I: A real-life study on acquired skills from using an adrenaline autoinjector. Int Arch Allergy Immunol 2013; 160: 301-306.
65. Edwards ES, Edwards ET, Gunn R, Patterson R, North R: Design validation and labeling comprehension study for a new epinephrine autoinjector. Ann Allergy Asthma Immunol 2013; 110: 189-193.
66. Camargo CA Jr, Guana A, Wang S, Simons FER: Auvi-Q versus EpiPen: preferences of adults, caregivers and children. J Allergy Clin Immunol: In Practice 2013; 1: 266-272.
67. Jacobsen RC, Toy S, Bonham AJ, Salomone JA 3rd, Ruthstrom J, Gratton M: Anaphylaxis knowledge among paramedics: results of a national survey. Prehosp Emerg Care 2012; 16: 527-534.
68. Sicherer SH, Vargas PA, Groetch ME, Christie L, Carlisle SK, Noone S, Jones SM: Development and validation of educational materials for food allergy. J Pediatr 2012; 160: 651-656.
69. Simons E, Sicherer SH, Simons FER: Timing the transfer of responsibilities for anaphylaxis recognition and use of an epinephrine auto-injector from adults to children and teenagers: pediatric allergists' perspective. Ann Allergy Asthma Immunol 2012; 108: 321-325.
70. Simons E, Sicherer SH, Weiss C, Simons FER: Caregivers' perspectives on timing the transfer of responsibilities for anaphylaxis recognition and treatment from adults to children and teenagers. J Allergy Clin Immunol: In Practice 2013; 1: 309-311.
71. Kelleher MM, Hourihane JO, Dunngalvin A, Cullinane C, Fitzsimons J, Sheikh A: A 24-h helpline for access to expert management advice for food allergy-related anaphylaxis in children: protocol for a pragmatic randomised controlled trial. BMJ Open 2012; 2:e001282.
72. Mehl A, Niggemann B, Keil T, Wahn U, Beyer K: Skin prick test and specific serum IgE in the diagnostic evaluation of suspected cow's milk and hen's egg allergy in children: does one replace the other? Clin Exp Allergy 2012; 42: 1266-1272.
73. Ludman S, Wassenberg J, Du Toit G, Fox AT, Lack G, Eigenmann PA: Paediatric oral peanut challenges: a comparison of practice in London and Western Switzerland. Allergy 2013; 68: 539-541.
74. Sicherer SH, Wood RA: Advances in diagnosing peanut allergy. J Allergy Clin Immunol: In Practice 2013; 1: 1-13.
75. Strohmeier B, Aberer W, Bokanovic D, Komericki P, Sturm GJ: Simultaneous intradermal testing with hymenoptera venoms is safe and more efficient than sequential testing. Allergy 2013; 68: 542-544.
76. Ramirez LF, Pereira A, Chiriac AM, Bonnet-Boyer MC, Demoly P: Negative predictive value of skin tests to neuromuscular blocking agents. Allergy 2012; 67: 439-441.
77. Lafuente A, Javaloyes G, Berroa F, Goikoetxea MJ, Moncada R, Nunez-Cordoba JM, Cabrera-Freitag P, D'Amelio C, Sanz ML, Gastaminza G: Early skin testing is effective for diagnosis of hypersensitivity reactions occurring during anesthesia. Allergy 2013; 68: 820-822.
78. Wood RA, Sicherer SH, Vickery BP, Jones SM, Liu AH, Fleischer DM, Henning AK, Mayer L, Burks AW, Grishin A, Stablein D, Sampson HA: The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol 2013; 131: 805-812.e4.
79. Glez PP, Franco YB, Matheu V: MIP-1alpha, MCP-1, and desensitization in anaphylaxis from cow's milk. N Engl J Med 2012; 367: 282-284.
80. Yeung JP, Kloda LA, McDevitt J, Ben-Shoshan M, Alizadehfar R: Oral immunotherapy for milk allergy. Cochrane Database Syst Rev 2012; 11:CD009542.
81. Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW, Stablein D, Henning AK, Vickery BP, Liu AH, Scurlock AM, Shreffler WG, Plaut M, Sampson HA: Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012; 367: 233-243.
82. Fleischer DM, Burks AW, Vickery BP, Scurlock AM, Wood RA, Jones SM, Sicherer SH, Liu AH, Stablein D, Henning AK, Mayer L, Lindblad R, Plaut M, Sampson HA: Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 2013; 131: 119-127.
83. Nadeau KC, Kohli A, Iyengar S, DeKruyff RH, Umetsu DT: Oral immunotherapy and anti-IgE antibody-adjunctive treatment for food allergy. Immunol Allergy Clin North Am 2012; 32: 111-133.
84. Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, Oude Elberink JNG: Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev 2012; 10:CD008838.
85. Brown SGA, Wiese MD, van Eeden P, Stone SF, Chuter CL, Gunner J, Wanandy T, Phillips M, Heddle RJ: Ultrarush versus semirush initiation of insect venom immunotherapy: a randomized controlled trial. J Allergy Clin Immunol 2012; 130: 162-168.
86. Scherer K, Brockow K, Aberer W, Gooi JHC, Demoly P, Romano A, et al. Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group. Allergy 2013; 68: 844-852.
87. Baldo BA, McDonnell NJ, Pham NH: The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form? Mini Rev Med Chem 2012; 12: 701-712.
88. Kelso JM, Greenhawt MJ, Li JT, Nicklas RA, Bernstein DI, Blessing-Moore J, Cox L, Khan D, Lang DM, Oppenheimer J, Portnoy JM, Randolph CR, Schuller DE, Spector SL, Tilles SA, Wallace D: Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol 2012; 130: 25-43.